arrow
F

Florian Clatot

centre henri-becquerel
H指数:35
被引数:4,096

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Phase II study of cabozantinib in recurrent or metastatic cervical cancer after progression on platinum-based chemotherapy (CABOCOL)

CABOCOL研究中卡博替尼治疗复发或转移性宫颈癌的II期研究(在铂类化疗进展后)

2026-10-230
PRE
The role of body mass index at diagnosis in patients with inflammatory breast cancer

炎性乳腺癌患者诊断时体重指数的作用

2025-10-120
OAAI
Prognostic value of circulating HER2 extracellular domain in patients with HER2-positive metastatic breast carcinoma treated with TDM-1 (trastuzumab emtansine)

循环HER2细胞外域在HER2阳性转移性乳腺癌患者接受TDM-1(trastuzumab emtansine)治疗中的预后价值

2025-08-030
PRE
Retrospective multicentric survival analysis of patients receiving TPEx regimen as first-line treatment of recurrent and/or metastatic head and neck squamous cell carcinoma

回顾性多中心生存分析:接受TPEx方案作为复发和/或转移性头颈部鳞状细胞癌一线治疗的患者的生存分析

2025-04-010
OAAI
Retrospective multicentric survival analysis of patients receiving TPEx regimen (docetaxel, platinum and cetuximab) as first line treatment of recurrent or metastatic squamous cell carcinoma of the head and neck

回顾性多中心生存分析:接受TPEx方案(多西他赛、铂类和西妥昔单抗)作为复发或转移性头颈部鳞状细胞癌一线治疗的患者

2024-09-010
PRE
CSFctDNA as a surrogate for tumor tissue DNA in BC pts with CNS metastases: First results from the Brainstorm program (Oncodistinct 006)
2024-04-050
PRE
Pregnancy After Breast Cancer in Young BRCA Carriers
2024-01-0220
OA
BrainStorm: a multicenter international study to tackle CNS metastases in solid tumors
2023-10-190
PRE
Real-world clinical and survival outcomes of patients with early relapsed triple-negative breast cancer from the ESME national cohort
2023-08-018
PRE
Extended follow-up of a phase 2 trial of xevinapant plus chemoradiotherapy in high-risk locally advanced squamous cell carcinoma of the head and neck: a randomised clinical trial
2023-04-0123
OA